Category

Daily Briefs

Daily Brief ESG: Companies that Wish to Distance from Facing Shareholders Are Unlikely to Achieve Management Reform and more

By | Daily Briefs, ESG

In today’s briefing:

  • Companies that Wish to Distance from Facing Shareholders Are Unlikely to Achieve Management Reform


Companies that Wish to Distance from Facing Shareholders Are Unlikely to Achieve Management Reform

By Aki Matsumoto

  • The increase in stock splits reflects a shift toward meeting the needs of individual shareholders of listed companies, occurring as cross-shareholdings decline and the presence of overseas investors grows.
  • Companies unwilling to increase foreign ownership further use stock splits to boost individual shareholders. Companies with low stock prices use it to meet as a tool of TSE’s P/B request.
  • It has become clear that increasing the foreign ownership is a higher priority than the increased costs associated with the rise in the number of shareholders resulting from stock split.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japan Activism Briefs: Yamaha Motor and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Activism Briefs: Yamaha Motor, Tamron, NPC
  • Ohayo Japan | Dow Jones Closes Above 47,000 for First Time
  • Japan Morning Connection: SOX to New Highs After CPI Greenlights Further Cuts and Risk-On Mood


Japan Activism Briefs: Yamaha Motor, Tamron, NPC

By Mark Chadwick

  • Yamaha Motor (7272) | Silchester raised stake to 8.8%; shares down 20% despite core motorcycles/marine generating 20-30% ROIC, undermined by ¥62bn losses in RVs/Robotics.
  • Tamron (7740) | Effissimo increased holding to 13%; company trades at 6x EBIT with 20%+ margins, expanding from camera lenses into automotive ADAS and industrial optics.
  • NPC (6255) | LIM acquired 6% stake in solar equipment maker down 20% year-to-date, betting on perovskite cycle recovery despite withdrawn guidance and customer weakness.

Ohayo Japan | Dow Jones Closes Above 47,000 for First Time

By Mark Chadwick

  • U.S. stocks surged to record highs on Friday following cooler-than-expected September inflation data that reinforced expectations for continued Federal Reserve rate cuts
  • US-China officials negotiated a trade deal framework to pause higher US tariffs and Chinese rare earth export controls
  • This week: BOJ is expected to hold rates at 0.50%; Takaichi to meet with Trump

Japan Morning Connection: SOX to New Highs After CPI Greenlights Further Cuts and Risk-On Mood

By Andrew Jackson

  • IBM continues to rerate as a Quantum name after announcing regular AMD chips can be used for qubit error correction.
  • Trump in Japan for the next 3-days likely to see defense, soybean and auto re-import pledges, but still waiting for a nuclear Takaichi.
  • Shin-Etsu earnings and guidance missed on PVC outlook, but this could be a bottom as US building sentiment set to improve.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: ECM Weekly (27 October 2025)- Sany and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB
  • Pre-IPO Sichuan Biokin Pharmaceutical (PHIP Updates) – Some Points Worth the Attention


ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, Hong Kong and India markets appear to be gearing up for a year end rush.
  • On the placements front, there were no large deals this week but we did have a look at the upcoming lockup expiries.

Pre-IPO Sichuan Biokin Pharmaceutical (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Chairman of the Board Zhu Yi hopes to build Biokin into an MNC with the success of BL-B01D1.In other words, Zhu Yi is prepared to bet all on this product.
  • Biokin’s valuation should be lower than Akeso Biopharma Inc (9926 HK), but higher than RemeGen. If BL-B01D1’s development is successful, Biokin’s future valuation ceiling will be higher than Kelun Bio.  
  • Global peak sales revenue share of BL-B01D1 could reach approximately RMB20 billion. If based on P/S of 5x, market value is RMB100 billion. So, there’s bubble in valuation in A-share.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Tsuruha (3391 JP)/Welcia (3141 JP): Index Promotion & Passive Flows Likely Priced In and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Tsuruha (3391 JP)/Welcia (3141 JP): Index Promotion & Passive Flows Likely Priced In
  • Merger Arb Mondays (27 Oct) – Dongfeng, ENN, Joy City, Minmetals, Soft99, Ashimori, Pacific Ind
  • Seres (9927 HK): Index Inclusion Timeline for a Max Offering of US$2.2bn; Big Discount to A-Shares
  • Weekly Deals Digest (26 Oct) – Digital Holdings, Soft99, Joy City, Minmetals, Sany, Seres, Pony AI
  • HSBC (5 HK) Earnings on 28 Oct, 12:00 HKT: Price Action and Option Insights
  • Lenskart IPO: Earliest Index Inclusion in June
  • HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound
  • A/H Premium Tracker (2 Wks to 24 Oct 2025):  Beautiful Skew Behaving Badly; High Div SOEs


Tsuruha (3391 JP)/Welcia (3141 JP): Index Promotion & Passive Flows Likely Priced In

By Brian Freitas



Seres (9927 HK): Index Inclusion Timeline for a Max Offering of US$2.2bn; Big Discount to A-Shares

By Brian Freitas

  • Seres Group (601127 CH) could raise up to HK$17.4bn (US$2.24bn) in its H-share listing if the Offer Size Adjustment Option and the Overallotment Option are both exercised.
  • There is a big allocation to cornerstone investors that is locked up for 6 months. That eliminates the already small possibility of Fast Entry inclusion to global indexes.
  • Seres (9927 HK) should be added to Southbound Stock Connect from the open of trading on 1 December following the end of the Price Stabilisation period.

Weekly Deals Digest (26 Oct) – Digital Holdings, Soft99, Joy City, Minmetals, Sany, Seres, Pony AI

By Arun George


HSBC (5 HK) Earnings on 28 Oct, 12:00 HKT: Price Action and Option Insights

By Gaudenz Schneider

  • Context: Index heavyweight HSBC (5 HK) / HSBC (HSBA LN) is set to report results on 28 October at 12:00 HKT — during the Hong Kong trading lunch break.
  • Timing & Trading: The 30 Oct and 31 Oct option expiries offer direct instruments to gauge HSBC’s post-earnings volatility — or to take targeted exposure to, or hedge, the event.
  • Expected Move: Historical data reveals HSBC’s announcement-day moves are significantly larger than on average trading days, with options currently pricing in a remarkably aligned ± 3.1% implied move.

Lenskart IPO: Earliest Index Inclusion in June

By Brian Freitas

  • Lenskart Solutions (0370405Z IN) is looking to list on the exchanges by selling 181.05m shares via a primary and secondary offering to raise US$829m at a valuation of US$7.95bn.
  • The price band has been set at INR 382-402/share, and the issue is likely to price at the top end of the range.
  • The stock will not get Fast Entry to global indices. Inclusion at regular rebalances will commence in June 2026 but flow will be small given the low float.

HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound

By Travis Lundy

  • Gross SOUTHBOUND volumes just over US$21bn a day two weeks ago as markets fell sharply. About two-thirds that this past week as indices rebounded. High-div SOEs seeing buying demand.
  • The recommended name was short Fuyao Glass Industry Group (3606 HK). The stock was -4.9% over two weeks, but the H outperformed its A by 0.55%.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The Southbound Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

A/H Premium Tracker (2 Wks to 24 Oct 2025):  Beautiful Skew Behaving Badly; High Div SOEs

By Travis Lundy

  • The last two weeks have seen “Beautiful Skew” behave badly across the ten trading days. CNOOC Ltd (883 HK) is trading too wide for its div into year-end.
  • The long reco on Guangzhou Automobile Group (2238 HK) two weeks ago saw the H-share rise 6.8% from the next day through Friday, and the H OUTperformed its A by 2.62%.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Curator’s Cut: Japan’s Defense Drive and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Curator’s Cut: Japan’s Defense Drive, Asia’s Vision Opportunities & US Diagnostics Picks
  • Shorting NOF (4403) Just Now Is Probably a Very Bad Idea
  • IHI (7013 JP): SAR Satellite Deal Adds to Takaichi Trade
  • China Healthcare Weekly (Oct.26) – Turning Point of Medical Device, Innovent-Takeda Deal Makes Sense
  • Bell Financial Group Ltd – ECM and brokerage conditions remain strong
  • Pegasystems: Application Modernization with AI & Cloud Services Are Upping The Ante!
  • Amazon.com Inc – Amazon’s Quiet Crisis: What Anthropic’s Defection Could Mean for AWS
  • Vertiv Is Powering the AI Revolution—Can Its NVIDIA Collaboration Change the Game?
  • Moody’s Corporation: An Insight Into The Moody’s Analytics Expansion and Recurring Revenue Diversification!
  • From Utility to Growth: Re‑rating Potential at Japan Exchange Group (8697.T)


Curator’s Cut: Japan’s Defense Drive, Asia’s Vision Opportunities & US Diagnostics Picks

By Pranav Rao

  • Welcome to Curator’s Cut — a fortnightly roundup of standout themes from the 1,000+ insights shared on Smartkarma. After a brief one-issue break, we’re back with fresh perspectives.
  • In this cut, we explore Japan’s renewed defense ambitions, Asia’s eyewear evolution, and US diagnostics’ next frontiers.
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next

Shorting NOF (4403) Just Now Is Probably a Very Bad Idea

By Michael Allen

  • Japan’s defense budget may be set to surge by about 50%, making NOF’s ammunition business a hot theme.
  • Be careful though. NOF’s munitions segment faces production limits and slow capacity expansion, capping near-term profit growth even with new defense spending.
  • We think NOF is overvalued, even as we acknowledge consensus forecasts are probably too low. But shorting now would probably just be fighting the tape. Save this idea for later.

IHI (7013 JP): SAR Satellite Deal Adds to Takaichi Trade

By Scott Foster

  • New Japanese Prime Minister Sanae Takaichi aims to raise defense spending to 2% of GDP this fiscal year, two years ahead of the original schedule.
  • Takaichi also wants to accelerate investment in advanced defense technologies. IHI, which recently signed an agreement with ICEYE to build earth observations satellites, should be among the beneficiaries.
  • IHI’s sales and profit comparisons should turn positive during FY Mar-26. A 7-for-1 stock split effective October 1, 2025, makes the shares more attractive to retail investors. 

China Healthcare Weekly (Oct.26) – Turning Point of Medical Device, Innovent-Takeda Deal Makes Sense

By Xinyao (Criss) Wang

  • Whether it is big pharmaceutical company or Biopharma that currently generates revenue/profits mainly through one or two products, they may not be able to “defend” successfully in long term.
  • The logic for innovative medical device is similar to innovative drugs – It takes 1-2 years from the turning point of policies to the turning point of fundamentals.
  • The Innovent-Takeda deal is logical. However, stock price performance of Innovent was disappointing, which is due to the “turning point” of HK biotech sector.The current decline is far from over.

Bell Financial Group Ltd – ECM and brokerage conditions remain strong

By Research as a Service (RaaS)

  • Bell Financial Group Ltd (ASX:BFG) is a diversified provider of financial products and software solutions within, and increasingly outside, its traditional full-service stockbroking business.
  • The latest ASX ECM data suggests raisings in the September quarter were 8% above the previous corresponding period (pcp) and 45% above the June 2025 quarter.
  • In terms of market share, the latest Dealogic data suggests Bell Potter has held share relative to the pcp, while raising US$0.75b (A$1.2b) against US$0.63b (A$1.0b) year to date October 2025 (+20%).

Pegasystems: Application Modernization with AI & Cloud Services Are Upping The Ante!

By Baptista Research

  • Pegasystems’ third-quarter financial results from 2025 highlight both strengths and challenges for the company.
  • The reported results underline Pegasystems’ ability to execute its cloud strategy and leverage artificial intelligence innovations, which have been key growth drivers.
  • The company’s focus on AI-driven process automation and orchestration platforms remains a cornerstone of its strategy, which is increasingly appealing to financial services and other regulated industries due to its approach of ensuring predictable workflows.

Amazon.com Inc – Amazon’s Quiet Crisis: What Anthropic’s Defection Could Mean for AWS

By Baptista Research

  • Amazon’s long-term AI ambitions are being tested as its $8 billion bet on Anthropic faces a potential turning point.
  • Recent reports reveal that Anthropic, the AI startup behind the Claude language model and currently enjoying a $5 billion annualized revenue run rate, is in talks with Alphabet’s Google for a cloud-computing deal potentially worth tens of billions of dollars.
  • This shift, if finalized, could grant Anthropic access to Google’s advanced AI chips, a key competitive asset as workloads grow increasingly complex.

Vertiv Is Powering the AI Revolution—Can Its NVIDIA Collaboration Change the Game?

By Baptista Research

  • Vertiv Corporation reported robust financial performance for the third quarter of 2025, indicating strong growth across several metrics.
  • The company reported an adjusted diluted earnings per share (EPS) of $1.24, a 63% increase year-over-year, largely driven by enhanced operating profit margins, which stood at 22.3%, up from the previous year.
  • Organic net sales grew 28%, with the Americas contributing a substantial 43%, and the AsiaPacific (APAC) region also showing a strong performance with a 21% increase.

Moody’s Corporation: An Insight Into The Moody’s Analytics Expansion and Recurring Revenue Diversification!

By Baptista Research

  • Moody’s Corporation reported a strong financial performance in its third-quarter results for 2025, achieving a record revenue of over $2 billion, marking an 11% increase from the previous year.
  • The corporation has also raised full-year guidance across nearly all metrics, demonstrating considerable growth and operational leverage.
  • The adjusted operating margin stood at 53%, a 500-basis point improvement from the previous year, and adjusted diluted EPS increased by 22% to $3.92, highlighting robust earnings power.

From Utility to Growth: Re‑rating Potential at Japan Exchange Group (8697.T)

By Rikki Malik

  • A stock that should benefit from the resumption of Japan’s bull market
  • Utility type stock poised to rerate  as a growth narrative starts
  • The stock has recently broken out of its 18 month downtrend

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Ready for the Contrarian Gold Trade? and more

By | Daily Briefs, Macro

In today’s briefing:

  • Ready for the Contrarian Gold Trade?
  • Time to Sound the All-Clear?


Ready for the Contrarian Gold Trade?

By Cam Hui

  • We have been bull bulls, but point and figure charts of gold and gold miners show that they are either very near or have outrun their measured price objectives.
  • Tactically, the contrarian trade would be to sell gold and buy bonds.
  • However, a cycle analysis leads us to conclude that the market is undergoing a shift to a hard asset price leadership cycle.

Time to Sound the All-Clear?

By Cam Hui

  • The U.S. stock market’s technical conditions are turning more constructive.
  • Market internals such as breadth and risk appetite indicators have stopped deteriorating and they are starting to heal
  • Risks remain, and we would like to see the resolution of key event risks before sounding the all-clear signal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Rio Tinto , Bell Financial, Kinatico and more

By | Australia, Daily Briefs

In today’s briefing:

  • Solactive Global Lithium Index Rebalance: Two Adds and Capping Changes
  • Bell Financial Group Ltd – ECM and brokerage conditions remain strong
  • Kinatico Ltd – Q1 SaaS revenue up 58% to $4.8m, now 53% of total


Solactive Global Lithium Index Rebalance: Two Adds and Capping Changes

By Brian Freitas

  • Solactive has announced the review results for the Global Lithium Index. There are two additions for the index and there will also be capping changes for some stocks.
  • Estimated one-way turnover is 26.3% and will result in a round-trip trade of US$813m. There are some stocks with over 0.5x ADV to trade.
  • The index has broken out of the secular downtrend, but investors continue to redeem units from the ETFs tracking the index.

Bell Financial Group Ltd – ECM and brokerage conditions remain strong

By Research as a Service (RaaS)

  • Bell Financial Group Ltd (ASX:BFG) is a diversified provider of financial products and software solutions within, and increasingly outside, its traditional full-service stockbroking business.
  • The latest ASX ECM data suggests raisings in the September quarter were 8% above the previous corresponding period (pcp) and 45% above the June 2025 quarter.
  • In terms of market share, the latest Dealogic data suggests Bell Potter has held share relative to the pcp, while raising US$0.75b (A$1.2b) against US$0.63b (A$1.0b) year to date October 2025 (+20%).

Kinatico Ltd – Q1 SaaS revenue up 58% to $4.8m, now 53% of total

By Research as a Service (RaaS)

  • Kinatico Ltd (ASX:KYP) is a ‘Know Your People” regtech company providing workforce compliance monitoring and management technology and services.
  • KYP announced at its 24 October AGM that its Q1 FY26 revenue had increased 14% on the previous corresponding period (pcp) to a record $9.1m, with Subscription-as-a-Service (SaaS) revenue for the quarter increasing 58% on the previous corresponding period (pcp) to $4.8m or 53% of total revenue.
  • EBITDA for the quarter increased 21% to $1.4m.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Dongfeng Motor, Seres Group , Innovent Biologics Inc, HSBC Holdings, Bloks Group, CNOOC Ltd, Sichuan Biokin Pharmaceutical Co Ltd, Sany Heavy Industry, WuXi AppTec, Guangzhou Automobile Group and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (27 Oct) – Dongfeng, ENN, Joy City, Minmetals, Soft99, Ashimori, Pacific Ind
  • Seres (9927 HK): Index Inclusion Timeline for a Max Offering of US$2.2bn; Big Discount to A-Shares
  • China Healthcare Weekly (Oct.26) – Turning Point of Medical Device, Innovent-Takeda Deal Makes Sense
  • HSBC (5 HK) Earnings on 28 Oct, 12:00 HKT: Price Action and Option Insights
  • Bloks Group (0325.HK): Stock Premium Is Not Justified, Growth Has Slowed, ~30% Downside
  • A/H Premium Tracker (2 Wks to 24 Oct 2025):  Beautiful Skew Behaving Badly; High Div SOEs
  • Pre-IPO Sichuan Biokin Pharmaceutical (PHIP Updates) – Some Points Worth the Attention
  • ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB
  • WuXi AppTec (2359 HK): Continued Strong Momentum in 3Q Leads to Consecutive FY Guidance Raise
  • HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound



Seres (9927 HK): Index Inclusion Timeline for a Max Offering of US$2.2bn; Big Discount to A-Shares

By Brian Freitas

  • Seres Group (601127 CH) could raise up to HK$17.4bn (US$2.24bn) in its H-share listing if the Offer Size Adjustment Option and the Overallotment Option are both exercised.
  • There is a big allocation to cornerstone investors that is locked up for 6 months. That eliminates the already small possibility of Fast Entry inclusion to global indexes.
  • Seres (9927 HK) should be added to Southbound Stock Connect from the open of trading on 1 December following the end of the Price Stabilisation period.

China Healthcare Weekly (Oct.26) – Turning Point of Medical Device, Innovent-Takeda Deal Makes Sense

By Xinyao (Criss) Wang

  • Whether it is big pharmaceutical company or Biopharma that currently generates revenue/profits mainly through one or two products, they may not be able to “defend” successfully in long term.
  • The logic for innovative medical device is similar to innovative drugs – It takes 1-2 years from the turning point of policies to the turning point of fundamentals.
  • The Innovent-Takeda deal is logical. However, stock price performance of Innovent was disappointing, which is due to the “turning point” of HK biotech sector.The current decline is far from over.

HSBC (5 HK) Earnings on 28 Oct, 12:00 HKT: Price Action and Option Insights

By Gaudenz Schneider

  • Context: Index heavyweight HSBC (5 HK) / HSBC (HSBA LN) is set to report results on 28 October at 12:00 HKT — during the Hong Kong trading lunch break.
  • Timing & Trading: The 30 Oct and 31 Oct option expiries offer direct instruments to gauge HSBC’s post-earnings volatility — or to take targeted exposure to, or hedge, the event.
  • Expected Move: Historical data reveals HSBC’s announcement-day moves are significantly larger than on average trading days, with options currently pricing in a remarkably aligned ± 3.1% implied move.

Bloks Group (0325.HK): Stock Premium Is Not Justified, Growth Has Slowed, ~30% Downside

By Andrei Zakharov

  • Bloks Group shares returned ~47% for IPO investors as of today, trailing the HSI’s 30% gain. The stock peaked at HK$190+ and fell ~55% over the following four months.
  • Shares saw pressure after lockup restrictions expired in July. Until this month, the lockup provision had prevented the majority shareholder and other early investors from selling their shares. 
  • The company’s revenue grew ~28% YoY in the first half of 2025, raising potential concerns of continued slowdown in sales of assembly character toys. Expect stock underperformance to continue.

A/H Premium Tracker (2 Wks to 24 Oct 2025):  Beautiful Skew Behaving Badly; High Div SOEs

By Travis Lundy

  • The last two weeks have seen “Beautiful Skew” behave badly across the ten trading days. CNOOC Ltd (883 HK) is trading too wide for its div into year-end.
  • The long reco on Guangzhou Automobile Group (2238 HK) two weeks ago saw the H-share rise 6.8% from the next day through Friday, and the H OUTperformed its A by 2.62%.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

Pre-IPO Sichuan Biokin Pharmaceutical (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Chairman of the Board Zhu Yi hopes to build Biokin into an MNC with the success of BL-B01D1.In other words, Zhu Yi is prepared to bet all on this product.
  • Biokin’s valuation should be lower than Akeso Biopharma Inc (9926 HK), but higher than RemeGen. If BL-B01D1’s development is successful, Biokin’s future valuation ceiling will be higher than Kelun Bio.  
  • Global peak sales revenue share of BL-B01D1 could reach approximately RMB20 billion. If based on P/S of 5x, market value is RMB100 billion. So, there’s bubble in valuation in A-share.

ECM Weekly (27 October 2025)- Sany, Seres, PonyAI, WeRide, CIG, JST, Lenskart, Horizon, CRB

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, Hong Kong and India markets appear to be gearing up for a year end rush.
  • On the placements front, there were no large deals this week but we did have a look at the upcoming lockup expiries.

WuXi AppTec (2359 HK): Continued Strong Momentum in 3Q Leads to Consecutive FY Guidance Raise

By Tina Banerjee

  • WuXi AppTec (2359 HK) has announced 3Q25 result, with revenue growing 15% YoY and net profit increasing 83% YoY. U.S. remains the main driving force behind the company’s strong performance.
  • With continuous capacity expansion to better meet customer demand, backlog for continuing operations reached a record high of RMB60B as of September 30, 2025, up 41% YoY.
  • Based on the current momentum and confidence in customers’ ongoing demand for enabling services, Wuxi AppTec has further raised its full-year revenue growth guidance to 17–18% from 13–17%.

HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound

By Travis Lundy

  • Gross SOUTHBOUND volumes just over US$21bn a day two weeks ago as markets fell sharply. About two-thirds that this past week as indices rebounded. High-div SOEs seeing buying demand.
  • The recommended name was short Fuyao Glass Industry Group (3606 HK). The stock was -4.9% over two weeks, but the H outperformed its A by 0.55%.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The Southbound Flow Monitor and AH Pairs Monitor are both there – free – for all SK readers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Pegasystems Inc, Amazon, Vertiv Holdings Co, Moody’s Corp, Balchem Corp, United Rentals, Badger Meter, Las Vegas Sands, Reddit , EngageSmart LLC and more

By | Daily Briefs, United States

In today’s briefing:

  • Pegasystems: Application Modernization with AI & Cloud Services Are Upping The Ante!
  • Amazon.com Inc – Amazon’s Quiet Crisis: What Anthropic’s Defection Could Mean for AWS
  • Vertiv Is Powering the AI Revolution—Can Its NVIDIA Collaboration Change the Game?
  • Moody’s Corporation: An Insight Into The Moody’s Analytics Expansion and Recurring Revenue Diversification!
  • Balchem Corporation: Human Nutrition & Specialty Products Can Drive Future Growth!
  • United Rentals’ Infrastructure Playbook: How the IIJA Is Driving Solid Demand!
  • Badger Meter: An Insight Into Its BlueEdge, Smart Water Solutions & Other Major Drivers!
  • Las Vegas Sands’ $8 Billion Bet: Inside the Singapore Expansion That’s Redefining Luxury Tourism!
  • Reddit’s $465 Million Ad Boom Faces a Bot-Fueled Bust—But Can It Survive the AI Flood?
  • Primer: EngageSmart LLC (ESMT US) – Oct 2025


Pegasystems: Application Modernization with AI & Cloud Services Are Upping The Ante!

By Baptista Research

  • Pegasystems’ third-quarter financial results from 2025 highlight both strengths and challenges for the company.
  • The reported results underline Pegasystems’ ability to execute its cloud strategy and leverage artificial intelligence innovations, which have been key growth drivers.
  • The company’s focus on AI-driven process automation and orchestration platforms remains a cornerstone of its strategy, which is increasingly appealing to financial services and other regulated industries due to its approach of ensuring predictable workflows.

Amazon.com Inc – Amazon’s Quiet Crisis: What Anthropic’s Defection Could Mean for AWS

By Baptista Research

  • Amazon’s long-term AI ambitions are being tested as its $8 billion bet on Anthropic faces a potential turning point.
  • Recent reports reveal that Anthropic, the AI startup behind the Claude language model and currently enjoying a $5 billion annualized revenue run rate, is in talks with Alphabet’s Google for a cloud-computing deal potentially worth tens of billions of dollars.
  • This shift, if finalized, could grant Anthropic access to Google’s advanced AI chips, a key competitive asset as workloads grow increasingly complex.

Vertiv Is Powering the AI Revolution—Can Its NVIDIA Collaboration Change the Game?

By Baptista Research

  • Vertiv Corporation reported robust financial performance for the third quarter of 2025, indicating strong growth across several metrics.
  • The company reported an adjusted diluted earnings per share (EPS) of $1.24, a 63% increase year-over-year, largely driven by enhanced operating profit margins, which stood at 22.3%, up from the previous year.
  • Organic net sales grew 28%, with the Americas contributing a substantial 43%, and the AsiaPacific (APAC) region also showing a strong performance with a 21% increase.

Moody’s Corporation: An Insight Into The Moody’s Analytics Expansion and Recurring Revenue Diversification!

By Baptista Research

  • Moody’s Corporation reported a strong financial performance in its third-quarter results for 2025, achieving a record revenue of over $2 billion, marking an 11% increase from the previous year.
  • The corporation has also raised full-year guidance across nearly all metrics, demonstrating considerable growth and operational leverage.
  • The adjusted operating margin stood at 53%, a 500-basis point improvement from the previous year, and adjusted diluted EPS increased by 22% to $3.92, highlighting robust earnings power.

Balchem Corporation: Human Nutrition & Specialty Products Can Drive Future Growth!

By Baptista Research

  • Balchem Corporation reported robust financial performance for the third quarter of 2025, setting record figures across key financial metrics.
  • The company achieved consolidated sales of $268 million, which marked an 11.5% increase from the prior year, and delivered record earnings from operations at $55 million, reflecting a 13.7% rise.
  • This resulted in a net income of $40 million, up by 19.1%.

United Rentals’ Infrastructure Playbook: How the IIJA Is Driving Solid Demand!

By Baptista Research

  • United Rentals reported its third-quarter results, showcasing some notable achievements alongside challenges that could impact its future performance.
  • The company experienced record revenue and adjusted EBITDA due to robust demand, particularly from large projects and key verticals.
  • Total revenue increased by 5.9% year-over-year to $4.2 billion, with rental revenue rising by 5.8% to $3.7 billion.

Badger Meter: An Insight Into Its BlueEdge, Smart Water Solutions & Other Major Drivers!

By Baptista Research

  • Badger Meter reported a robust third quarter in 2025, displaying continued growth and a solid financial footing.
  • The company achieved a 13% year-over-year increase in total sales, reaching $236 million.
  • This growth was mainly driven by the utility water product line, which saw a 14% increase, driven by higher ultrasonic meter volumes, BEACON Software sales, and water quality product sales.

Las Vegas Sands’ $8 Billion Bet: Inside the Singapore Expansion That’s Redefining Luxury Tourism!

By Baptista Research

  • Las Vegas Sands Corporation (LVS) has reported its third-quarter 2025 earnings, showcasing impressive performance, particularly in its Singapore operation, Marina Bay Sands (MBS), and significant improvements in Macau.
  • The company’s Financial Year 2025 demonstrates robust growth, but some challenges remain, especially in Macau.
  • The standout performer in this quarter for Las Vegas Sands was Marina Bay Sands, which delivered EBITDA of $743 million, pointing to an expected annual EBITDA well above the projected $2.5 billion, potentially nearing $2.8 or $2.9 billion.

Reddit’s $465 Million Ad Boom Faces a Bot-Fueled Bust—But Can It Survive the AI Flood?

By Baptista Research

  • Reddit has surged in prominence over the past year, benefiting from two fast-growing monetization channels: AI licensing and advertising.
  • With daily active users (DAUs) up 21% year-over-year and advertising revenue soaring 84% to $465 million in Q2 2025, Reddit is experiencing its most profitable quarters ever.
  • Strategic licensing agreements with OpenAI and Google have brought highmargin revenues to the company, capitalizing on Reddit’s vast trove of authentic, human-generated content.

Primer: EngageSmart LLC (ESMT US) – Oct 2025

By αSK

  • Privatization by Vista Equity Partners: In a significant strategic shift, EngageSmart was acquired by Vista Equity Partners for approximately $4.0 billion and taken private on January 26, 2024. This transaction fundamentally alters the investment landscape, as the company’s stock is no longer publicly traded. The partnership with a top-tier software investor like Vista is expected to accelerate growth and innovation.
  • Strong Position in Vertical SaaS: EngageSmart is a leading provider of vertically-tailored customer engagement software and integrated payment solutions. The company operates through two main segments, SMB Solutions and Enterprise Solutions, serving specific verticals like Health & Wellness, Government, Utilities, and Financial Services. This focused approach allows for deep industry integration and high customer retention.
  • Consistent Financial Outperformance: The company has demonstrated a robust track record of revenue growth and expanding profitability. For the third quarter of 2023, EngageSmart reported a 24% year-over-year increase in revenue to $97.7 million. This financial strength is driven by strong demand for its SaaS solutions, high digital adoption rates, and successful customer acquisition and expansion within its niche markets.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Lenskart Solutions and more

By | Daily Briefs, India

In today’s briefing:

  • Lenskart IPO: Earliest Index Inclusion in June


Lenskart IPO: Earliest Index Inclusion in June

By Brian Freitas

  • Lenskart Solutions (0370405Z IN) is looking to list on the exchanges by selling 181.05m shares via a primary and secondary offering to raise US$829m at a valuation of US$7.95bn.
  • The price band has been set at INR 382-402/share, and the issue is likely to price at the top end of the range.
  • The stock will not get Fast Entry to global indices. Inclusion at regular rebalances will commence in June 2026 but flow will be small given the low float.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars